Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES
Net income/(loss)	$ 2,967,218	$ 101,880
Adjustment to reconcile net income/(loss) to net cash provided by/(used in) operating activities
Change in derivative liabilities	(795,779)	2,657,910
Interest expense from derivative instruments	296,182	158,068
Employee stock compensation	568,522	222,304
Provision for doubtful accounts	130,346	132,767
Depreciation and amortization	358,150	340,224
Changes in operating assets and liabilities
Accounts receivable	(2,167,733)	(1,495,505)
Prepaid expenses	(101,216)	(25,742)
Other current assets	23,592	(20,704)
Other assets	4,607	(4,756)
Accounts payable and accrued expenses	462,972	615,803
Patent settlement liability	(858,702)	(455,871)
Deferred revenue	(22,277)	291,453
Net cash provided by/(used in) operating activities	865,882	2,517,831
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(242,384)	(260,378)
Net cash (used in) investing activities	(242,384)	(260,378)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayments of notes payable	(915,000)	(200,000)
Repayments of notes payable, related parties	(105,000)	(45,000)
Proceeds/(repayments) from revolving line of credit	(50,000)	(1,500,000)
Proceeds from Stock Options Exercised	35,250	129,500
Proceeds from exercise of warrants	155,000	0
Net cash provided by/(used in) financing activities	(879,750)	(1,615,500)
Effect of exchange rate changes on fixed and intangible assets	(19,797)	6,310
Effect of exchange rate changes on cash and cash equivalents	13,268	(44,150)
Net increase/(decrease) in cash and cash equivalents	(262,781)	604,113
Cash and cash equivalents at beginning of period	1,439,332	835,219
Cash and cash equivalents at end of period	1,176,551	1,439,332
Supplemental disclosures of cash flow information:
Income taxes	1,194	1,069
Interest	1,051,909	1,445,684
Non-cash transactions:
Notes payable issued in exchange for existing notes payable	350,000	7,652,500
Restricted stock issuance/(forfeiture)	(2,834)	68,400
Common stock issued in exchange for 5% Series A Preferred Stock	0	3,637,724
Reclassification of conversion feature liability associated with convertible debt	402,567	0
Promasys B.V. [Member]
Non-cash transactions:
Promissory notes issued for accrued interest	$ 0	$ 450,000